Unknown

Dataset Information

0

Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc.


ABSTRACT: Overactivation of the innate immune system together with the impaired downstream pathway of type I interferon-responding genes is a hallmark of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc). To date, limited data on the cross-disease innate gene signature exists among those diseases. We compared therefore an innate gene signature of Toll-like receptors (TLRs), seven key members of the interleukin (IL)1/IL1R family, and CXCL8/IL8 in peripheral blood mononuclear cells from well-defined patients with active stages of RA (n = 36, DAS28 ? 3.2), SLE (n = 28, SLEDAI > 6), and SSc (n = 22, revised?EUSTAR?index > 2.25). Emerging diversity and abundance of the innate signature in RA patients were detected: RA was characterized by the upregulation of TLR3, TLR5, IL1RAP/IL1R3, IL18R1, and SIGIRR/IL1R8 when compared to SSc (P corr < 0.02) and of TLR2, TLR5, and SIGIRR/IL1R8 when compared to SLE (P corr < 0.02). Applying the association rule analysis, six rules (combinations and expression of genes describing disease) were identified for RA (most frequently included high TLR3 and/or IL1RAP/IL1R3) and three rules for SLE (low IL1RN and IL18R1) and SSc (low TLR5 and IL18R1). This first cross-disease study identified emerging heterogeneity in the innate signature of RA patients with many upregulated innate genes compared to that of SLE and SSc.

SUBMITTER: Petrackova A 

PROVIDER: S-EPMC6664489 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc.

Petrackova Anna A   Horak Pavel P   Radvansky Martin M   Skacelova Martina M   Fillerova Regina R   Kudelka Milos M   Smrzova Andrea A   Mrazek Frantisek F   Kriegova Eva E  

Journal of immunology research 20190716


Overactivation of the innate immune system together with the impaired downstream pathway of type I interferon-responding genes is a hallmark of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc). To date, limited data on the cross-disease innate gene signature exists among those diseases. We compared therefore an innate gene signature of Toll-like receptors (TLRs), seven key members of the interleukin (IL)1/IL1R family, and CXCL8/IL8 in peripheral blood m  ...[more]

Similar Datasets

| S-EPMC7020053 | biostudies-literature
| S-EPMC4090326 | biostudies-literature
| S-EPMC6109517 | biostudies-literature
| S-EPMC8554185 | biostudies-literature
| S-EPMC6491794 | biostudies-literature
| S-EPMC7872503 | biostudies-literature
| S-EPMC4910120 | biostudies-literature
| S-EPMC8165287 | biostudies-literature
| S-EPMC10491366 | biostudies-literature
| S-EPMC3990582 | biostudies-literature